Bellevue Life Sciences Acquisition 

$3.01
16
-$4.04-57.3% Friday 21:00

Statistics

Day High
4.43
Day Low
3.01
52W High
13.4
52W Low
3.01
Volume
315,724
Avg. Volume
8,158
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

20JanExpected
Q1 2022
Q3 2022
Q4 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Profitable
2022
2023
0Revenue
404,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLAC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Show more...
CEO
Mr. Kuk Hyoun Hwang
Country
US
ISIN
US0791741087

Listings

0 Comments

Share your thoughts

FAQ

What is Bellevue Life Sciences Acquisition stock price today?
The current price of BLAC is $3.01 USD — it has decreased by -57.3% in the past 24 hours. Watch Bellevue Life Sciences Acquisition stock price performance more closely on the chart.
What is Bellevue Life Sciences Acquisition stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bellevue Life Sciences Acquisition stocks are traded under the ticker BLAC.
What were Bellevue Life Sciences Acquisition earnings last quarter?
BLAC earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bellevue Life Sciences Acquisition revenue for the last year?
Bellevue Life Sciences Acquisition revenue for the last year amounts to 0 USD.
What is Bellevue Life Sciences Acquisition net income for the last year?
BLAC net income for the last year is 404,000 USD.
In which sector is Bellevue Life Sciences Acquisition located?
Bellevue Life Sciences Acquisition operates in the Financials sector.
When did Bellevue Life Sciences Acquisition complete a stock split?
Bellevue Life Sciences Acquisition has not had any recent stock splits.
Where is Bellevue Life Sciences Acquisition headquartered?
Bellevue Life Sciences Acquisition is headquartered in Bellevue, US.